AnaptysBio Inc (ANAB) — Capital Reinvestment Ratio
Latest as of December 2025:
0.00x
AnaptysBio Inc (ANAB) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($98.00 Million) in capital expenditures ($1.00K). See AnaptysBio Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$98.00 Million
USD
Capital Expenditures
$1.00K
USD
Data as of
Dec 2025
Most recent filing
AnaptysBio Inc Capital Reinvestment Ratio (2014–2025)
This chart tracks AnaptysBio Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for AnaptysBio Inc (2014–2025)
Year-by-year Capital Reinvestment Ratio for AnaptysBio Inc from 2014 to 2025. For live market cap and broader valuation context, see ANAB market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $19.70 Million | $87.00K | ▼ -55.5% |
| 2014 | 0.01x | $14.60 Million | $145.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow